ArticlePharmacological research2022

Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancy.

Hongye Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.